- Home
- RVNC vs WHF Comparison
RVNC vs WHF Comparison
Compare RVNC & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- WHF
- Stock Information
- Founded
- RVNC 1999
- WHF 2011
- Country
- RVNC United States
- WHF United States
- Employees
- RVNC N/A
- WHF N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- WHF Finance Companies
- Sector
- RVNC Health Care
- WHF Finance
- Exchange
- RVNC Nasdaq
- WHF Nasdaq
- Market Cap
- RVNC 546.4M
- WHF 275.2M
- IPO Year
- RVNC 2014
- WHF 2012
- Fundamental
- Price
- RVNC $5.29
- WHF $11.91
- Analyst Decision
- RVNC Buy
- WHF Hold
- Analyst Count
- RVNC 10
- WHF 3
- Target Price
- RVNC $10.86
- WHF $12.75
- AVG Volume (30 Days)
- RVNC 1.3M
- WHF 55.7K
- Earning Date
- RVNC 11-06-2024
- WHF 11-07-2024
- Dividend Yield
- RVNC N/A
- WHF 12.96%
- EPS Growth
- RVNC N/A
- WHF 62.93
- EPS
- RVNC N/A
- WHF 0.98
- Revenue
- RVNC $251,178,000.00
- WHF $100,458,000.00
- Revenue This Year
- RVNC $20.36
- WHF N/A
- Revenue Next Year
- RVNC $31.66
- WHF N/A
- P/E Ratio
- RVNC N/A
- WHF $12.09
- Revenue Growth
- RVNC 40.23
- WHF 1.22
- 52 Week Low
- RVNC $2.30
- WHF $10.95
- 52 Week High
- RVNC $9.75
- WHF $13.44
- Technical
- Relative Strength Index (RSI)
- RVNC 44.50
- WHF 55.90
- Support Level
- RVNC $5.10
- WHF $11.77
- Resistance Level
- RVNC $5.43
- WHF $11.98
- Average True Range (ATR)
- RVNC 0.17
- WHF 0.17
- MACD
- RVNC 0.02
- WHF 0.04
- Stochastic Oscillator
- RVNC 66.67
- WHF 80.70
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate attractive risk-adjusted returns for investors, primarily by originating senior secured loans to privately held small-cap companies across a broad range of industries.